To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.

NCT02540369 · clinicaltrials.gov ↗

COMPLETED

Status

2150

Enrollment

INDUSTRY

Sponsor class

Conditions

Wet Macular Degeneration

Interventions

DRUG: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

Sponsor

Bayer

Collaborators

[object Object]